Showing results (4201-4210 of 11,108) with videos related to
Sort By:
Pageof 1,111
Journal of the National Cancer Institute|May 10, 1989
Phase I study of an anti-breast cancer immunotoxin by continuous infusion: report of a targeted toxic effect not predicted by animal studiesB J Gould, M J Borowitz, E S Groves, et al.Journal of the National Cancer Institute|October 25, 2016
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal CancerGabriele Picco, Consalvo Petti, Francesco Sassi, et al.Journal of the National Cancer Institute|June 17, 2004
Polymorphisms associated with circulating sex hormone levels in postmenopausal womenAlison M Dunning, Mitch Dowsett, Catherine S Healey, et al.Journal of the National Cancer Institute|March 18, 1992
Phase II study: treatment of non-Hodgkin's lymphoma with an oral antitumor derivative of bis(2,6-dioxopiperazine)R Ohno, K Yamada, M Hirano, et al.Journal of the National Cancer Institute|November 4, 2004
Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probesRon H J Mathijssen, Floris A de Jong, Ron H N van Schaik, et al.Journal of the National Cancer Institute|November 4, 2004
Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agentsMatus Studeny, Frank C Marini, Jennifer L Dembinski, et al.Journal of the National Cancer Institute|June 3, 2004
An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1Michael Elkin, Adam Orgel, Hynda K KleinmanJournal of the National Cancer Institute|April 8, 2004
Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancerSandra M Swain, John W Wilson, Eleftherios P Mamounas, et al.Journal of the National Cancer Institute|April 8, 2004
A prospective study of plasma C-peptide and colorectal cancer risk in menJing Ma, Edward Giovannucci, Michael Pollak, et al.Journal of the National Cancer Institute|April 22, 2004
Lower-category benign breast disease and the risk of invasive breast cancerJiping Wang, Joseph P Costantino, Elizabeth Tan-Chiu, et al.Pageof 1,111